Rankings
▼
Calendar
BHVN Q2 2018 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$38M
Net Income
-$39M
EPS (Diluted)
$-1.01
QoQ Revenue Growth
NaN%
Balance Sheet
Total Assets
$239M
Total Liabilities
$120M
Stockholders' Equity
$119M
Cash & Equivalents
$217M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$38M
-$25M
-51.1%
Net Income
-$39M
-$38M
-2.2%
← Q1 2018
All Quarters
Q3 2018 →